Alpha Teknova, Inc.
Reports in 9d· 2026-05-06
-0.6% · 90d
$3.14
-0.04 (-1.26%)
After-Hours $3.13(-0.01)
News
(1)April 2026
TKNO annual proxy statement proposes electing directors and ratifying auditor
TKNOAlpha Teknova, Inc.
# 🗓️ What This Document Is 📄 This is Alpha Teknova, Inc.'s definitive Proxy Statement (DEF 14A) for the 2026 Annual Meeting of Stockholders. Think of this document as the company’s formal roadmap for its governance—it tells you exactly what decisions shareholders need to vote on, who is running t
Read summaryView on SEC EDGAR
Peers in Drug Manufacturers - Specialty & Generic
TAK#1
Takeda Pharmaceutical Company Limited
$57.78B-1.07%
ZTS#2
Zoetis Inc.
$50.46B+0.20%
HLN#3
Haleon plc
$43.61B+0.40%
TEVA#4
Teva Pharmaceutical Industries Limited
$36.05B+1.44%
UTHR#5
United Therapeutics Corporation
$25.19B-1.19%
VTRS#6
Viatris Inc.
$15.85B+0.29%
RGC#7
Regencell Bioscience Holdings Limited
$13.93B-2.46%
NBIX#8
Neurocrine Biosciences, Inc.
$13.21B-1.13%
ELAN#9
Elanco Animal Health Incorporated
$11.66B-0.59%
RDY#10
Dr. Reddy's Laboratories Limited
$10.92B+0.15%